Adding bevacizumab to oxaliplatin delays progression: Commentary Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Adding bevacizumab to oxaliplatin delays progression: Commentary |
| Keywords: | cancer survival; overall survival; clinical trial; disease course; bevacizumab; fluorouracil; placebo; drug efficacy; drug safety; drug withdrawal; treatment duration; unspecified side effect; capecitabine; disease free survival; neurotoxicity; colorectal cancer; bolus injection; metastasis; multiple cycle treatment; blood toxicity; combination chemotherapy; irinotecan; cancer inhibition; gastrointestinal toxicity; survival time; add on therapy; folinic acid; drug response; short survey; open study; oxaliplatin; drug treatment failure |
| Journal Title: | The Oncology Report |
| Issue: | Fall |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2007-09-01 |
| Start Page: | 34 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "Source: Scopus" |
MSK Authors
-
228Lichtman